EUVIMEDEUVIMED entdecken
Crossref

Unveiling VARS1: a key driver of colorectal cancer progression and immune modulation

Jiale Mei, Yuman Wu, Sicheng Zhao, Ning Qu, Haojun Xie, Dewei Guo, Tao Luo, Jiali Tang, Wenqi Luo

International Journal of Clinical Oncology · 2026

DOI: 10.1007/s10147-026-03084-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2026. Verfasst von Jiale Mei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal and Anal Disease Unit, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Repu…. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Valyl-tRNA synthetase 1 (VARS1), an aminoacyl-tRNA synthetase, has been implicated in various cancers, but its role in CRC remains unclear. This study investigated the expression pattern, clinical significance, biological functions, and potential molecular associations of VARS1 in CRC. METHODS: VARS1 expression was analyzed in CRC tissues using TCGA/GEO databases, immunohistochemistry, and Western blotting. Prognostic models were built via Cox regression and nomograms. In vitro, VARS1 was knocked down in CRC cell lines to assess proliferation (CCK-8, colony formation), migration/invasion (wound healing, Transwell), and EMT markers. Immune infiltration was evaluated with TIMER/CIBERSORT, single-cell analysis via Seurat/CellChat, drug sensitivity via GDSC2, and pathways via GO/KEGG/GSEA. RESULTS: VARS1 was overexpressed in CRC, correlating with poor survival as an independent risk factor. Knockdown suppressed cell proliferation, migration, invasion, accompanied by changes in EMT-related markers. High VARS1 expression was associated with reduced CD8+ T-cell infiltration and altered predicted cell-cell communication patterns within the tumor microenvironment. VARS1 was associated with altered predicted chemotherapy sensitivity. GSEA and phosphorylation analyses suggested a potential association between VARS1 and JAK/STAT pathway activity. CONCLUSION: Our findings suggest that VARS1 is associated with malignant phenotypes, immune-related features, and chemotherapy response in CRC, and may serve as a potential prognostic biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHumansCell ProliferationPrognosisGene Expression Regulation, NeoplasticFemaleCell MovementDisease ProgressionCell Line, TumorTumor MicroenvironmentBiomarkers, TumorEpithelial-Mesenchymal TransitionMale

Stichwörter der Autor:innen

CRCEMTImmune infiltrationVARS1

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Colorectal and Anal Disease Unit, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
  • Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
  • Department of Ultrasound, Guangxi Medical University Cancer Hospital, No.71 Hedi Road, Nanning, 530021, People's Republic of China. tangjiali@sr.gxmu.edu.cn.
  • Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China. tangjiali@sr.gxmu.edu.cn.
  • Department of Pathology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China. h2017024@sr.gxmu.edu.cn.
  • Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China. h2017024@sr.gxmu.edu.cn.

Förderung

  • Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation

Zitieren

APA

Mei, J., Wu, Y., Zhao, S., Qu, N., Xie, H., Guo, D., Luo, T., Tang, J., & Luo, W. (2026). Unveiling VARS1: a key driver of colorectal cancer progression and immune modulation. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-026-03084-1

Vancouver

Mei J, Wu Y, Zhao S, Qu N, Xie H, Guo D, et al. Unveiling VARS1: a key driver of colorectal cancer progression and immune modulation. International Journal of Clinical Oncology. 2026. doi:10.1007/s10147-026-03084-1

BibTeX
@article{Mei2026,
  author = {Mei, Jiale and Wu, Yuman and Zhao, Sicheng and Qu, Ning and Xie, Haojun and Guo, Dewei and Luo, Tao and Tang, Jiali and Luo, Wenqi},
  title = {Unveiling VARS1: a key driver of colorectal cancer progression and immune modulation},
  journal = {International Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1007/s10147-026-03084-1}
}
Kostenlos starten →